These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Molecular genetic mechanisms of the pathogenesis of gout and gouty nephropathy]. Filippova VG; Popova LA; Chekova VV; L'vova GN; Vasil'eva IM Ter Arkh; 1987; 59(8):72-6. PubMed ID: 3686449 [No Abstract] [Full Text] [Related]
15. [Allopurinol treatment of gout with special reference to patients with gouty nephropathy]. Chodorowski Z; Muszkowska-Penson J; Stolarczyk J Wiad Lek; 1974 Apr; 27(8):705-10. PubMed ID: 4826801 [No Abstract] [Full Text] [Related]
16. [Long-term therapy of gout and hyperuricemia]. Heidelmann G Z Gesamte Inn Med; 1973 Mar; 28(5):76-80. PubMed ID: 4705902 [No Abstract] [Full Text] [Related]
17. [Epidemiology and clinical aspect of primary gout. Observations between 1948 and 1968]. Mertz DP; Babucke G Munch Med Wochenschr; 1971 Apr; 113(16):617-24. PubMed ID: 5313655 [No Abstract] [Full Text] [Related]
18. Uric acid crystal-induced nephropathy: evidence for a specific renal lesion in a gouty family. Farebrother DA; Pincott JR; Simmons HA; Warren DJ; Dillon MJ; Cameron JS J Pathol; 1981 Oct; 135(2):159-68. PubMed ID: 7310574 [TBL] [Abstract][Full Text] [Related]